LifeStance Health Group Inc. Common Stock (NASDAQ: LFST)
According to the Complaint, LifeStance Health Group, Inc. provides outpatient mental health services in 31 states. LifeStance Health conducted its IPO on June 10, 2021, selling 46 million shares at $18.00 per share, raising $828 million in gross proceeds.
The Complaint alleges that the IPO's registration statement failed to disclose the following material facts: (i) that the number of virtual visits clients were undertaking utilizing LifeStance Health was decreasing as the COVID-19 lockdowns were being lifted, thereby flatlining LifeStance Health's out-patient/virtual revenue growth; (ii) that the percentage of in-person visits clients were undertaking utilizing LifeStance Health was increasing as the COVID-19 lockdowns were being lifted, thereby causing LifeStance Health's operating expenses to increase substantially; (iii) that LifeStance Health had lost a large number of physicians due to burn-out and, as a result, its physician retention rate had fallen significantly below the 87% highlighted in the IPO's registration statement and LifeStance Health had been expending additional costs to onboard new physicians who were less productive than the outgoing physicians they were replacing; and (iv) as a result, LifeStance Health's business metrics and financial prospects were not as strong as the IPO's registration statement represented.
On November 17, 2022, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed an amended Complaint on December 19. Defendants filed a Motion to Dismiss the amended Complaint on January 18, 2023. On April 10, the Court issued an Order denying Defendants' Motion to Dismiss.
Lead Plaintiff filed a Motion for Class Certification on June 2, 2023. On September 7, the Court issued an Order granting the Class Certification Motion.
The parties entered into a Stipulation of Settlement on October 13, 2023. The Court granted preliminary approval of the Settlement on October 25.